Loading organizations...
Muang Thai Fuchsia Ventures operates as the Corporate Venture Capital (CVC) arm of Muang Thai Group Holding, a prominent financial conglomerate in Thailand and Southeast Asia. The fund specializes in strategic investments across Insurtech, Healthtech, and Foodtech sectors, alongside other technologies designed to enhance consumers' health, wealth, and overall wellness. It offers both financial backing and integration into its parent group’s extensive ecosystem, fostering growth for its portfolio companies.
Established in 2017, the venture firm was founded with the core insight that innovation and technology are crucial drivers for improving quality of life and longevity. While specific individual founders are not detailed, its inception reflects a strategic move by Muang Thai Group Holding to actively participate in and shape the future of these critical industries. This allows the firm to leverage its parent company's industry expertise and market presence.
The firm's products, primarily strategic capital and ecosystem access, cater to startups and emerging companies developing solutions within its focus areas. Muang Thai Fuchsia Ventures aims to cultivate a portfolio that collectively works towards its long-term vision: significantly improving the quality and extending the longevity of life through technological advancements. This forward-looking approach positions the firm at the intersection of finance and societal well-being.
Muang Thai Fuchsia Ventures has 4 tracked investments across 3 companies. The latest tracked deal is $25.0M Other Equity in CXA Group in March 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 12, 2019 | CXA Group | $25.0M Other Equity | — | B Capital Group, Rosaline KOO, EDBI, Heritas Venture Fund, HSBC, Humanica, MDI Ventures, Singtel Innov8, Sumitomo Corporation Equity Asia |
| Mar 1, 2019 | CXA Group | $25.0M Series C | — | B Capital Group, Golden Gate Ventures, Pieter Kemps, Shailendra Singh, CXA Group, EDBI, Heritas Venture Fund, HSBC, Humanica, MDI Ventures, Singtel Innov8, Sumitomo Corporation Equity Asia |
| Jul 1, 2018 | C88 Financial Technologies | $28.0M Series C | BEN Elliott Gaicd | Blackbird Ventures Australia, Telstra Ventures, DEG, Fenghe Fund Management, Intervest, Kejora Capital, Kickstart Ventures, Pelago Capital, Responsability Investments |
| May 1, 2018 | Ultromics | $13.0M Series A | Oxford Science Enterprises | 24Haymarket, Andre Crawford Brunt, Dieter Spälti, GT Healthcare Capital Partners, Neptune, RT Ventures, Tanarra Capital |